The authors have evaluated the effectiveness of the protection of a new beta2-adrenergic compound, reproterol, against broncho-constriction induced by physical exercise in a group of individuals of paediatric age sensitive to broncho-stimulation.
This study has been carried out comparing reproterol with salbutamol, using placebo as a control, following a randomized single-blind crossover trial. The provocation test has been performed following the instructions of the Italian Society of Paediatrics. The drugs have been administered in the oral liquid form at the dose of 0·28 mg/kg and 0·1 mg/kg of reproterol and salbutamol, respectively.
The two substances have shown a similar preventive effectiveness in controlling exercise-induced asthma up to 2 hours from administration with reproterol having a stronger action at the beginning of the observation.
Get full access to this article
View all access options for this article.
References
1.
BattistiniAGrzincichG LBaroniA L (1980) Asma da sforzo e broncodilatatori. Valutazione strumentale di un nuovo beta-2-stimolante: il clenbuterolo. Rivista Italiana di Pediatria6, 313.
2.
BonaduceDFerraraNCanonicoVQuattrinSMazzaFRengoFCondorelliM (1981) Effetti della somministrazione acuta per via endovenosa di reproterolo su alcuni parametri spirometrici e cardiovascolari in pazienti affetti da broncopneumopatia cronica ostruttiva. Confronte con la terbutalina. Medicina Toracica3, 225.
3.
ČampragDDovatVBogdanovBČonkićBTaboriDAurichR (1979) Efficacia e tollerabilità del reproterolo somministrato per via endovenosa in lattanti e bambini. Medizinische Welt30, 897.
4.
Di MezzaFGiordanoLScognamiglioLMontanaroAMarmoE (1981) Reproterol and the muscle of the trachea and bronchi: in vitro and in vivo comparative studies with various drugs used in treatment of asthma. Respiration42, 175.
5.
FrancisP WKrastinsI R BLevisonH (1980) Oral and inhaled salbutamol in the prevention of exercise-induced bronchospasm. Pediatrics66, 103.
6.
GodfreySKonigP (1975) Suppression of exercise-induced asthma by salbutamol, theophylline, atropine, cromolyn and placebo in a group of asthmatic children. Pediatrics56, (suppl), 930.
7.
KennedyJ DHasmanFClayM J DJonesR S (1980) Comparison of actions of disodium cromoglycate and ketotifen on exercise-induced bronchoconstriction in childhood asthma. British Medical Journal281, 1458.
8.
MándiAGolgóczyGGalambosE (1977) Uber die bronchodilatatorische Wirkung von Reproterol. Arzneimittel Forschung (Drug Research)27, (la), 60.
9.
MarmoE (1981) Aspetti farmacodinamici del reproterolo. Clinica Terapeutica98, 481.
10.
MarmoE (1983) Sugli aspetti farmacodinamici della teofillina. Clinica Terapeutica106, 87.
11.
MarmoE (1978) Sulla reattività purinergica. Riforma Medica93, 725.
12.
MarmoEGiordanoLMateraM GDe CarloRRuggieroE (1982) In vitro effect of reproterol upon pulmonary, cardiac, vascular and intestinal 3,5 monophosphate phosphodiesterase nucleotide. Journal of Pharmacy and Pharmacology34, 342.
13.
MarmoEScognamiglioMGiordanoLPentimalliDMarfellaA (1982) In vitro effects of reproterol upon tracheobronchial, cardiac and cerebral adenylcyclase. Research Communications in Chemical Pathology and Pharmacology35, 389.
14.
MichaelSO'BrienS (1982) Effect of oral terbutaline on exercise-induced asthma. Annals of Allergy48, 151.
15.
MugnaiMFontanaGPanuccioP (1984) Il reproterolo nella prevenzione del broncospasmo indotto da nebbia ultrasonica di H2O distillata. Medicina Toracica Suppl. 6, 131.
16.
NicrosiniFPasottiG (1979) Studio clinico controllato in doppia cecità tra reproterolo, nuovo farmaco broncospasmolitico, ed aminofillina, dopo somministrazione endovenosa. Clinica Terapeutica90, 241.
17.
NiebchGObermeierKVerginHThiemerK (1977) Untersuchungen zur Pharmakokinetik und Biotransformation von Reproterol bei Tier und Mensch. Arzneimittel Forschung (Drug Research)27, (la), 37.
18.
PrimeF JBiancoSKamburoffP L (1979) Inhibition of artificially-induced asthma by reproterol (“Broncospasmin”)Current Medical Research and Opinion6, 364.
19.
Protocollo per la diagnosi di asma (1979) Rivista Italiana di Pediatria5, 411.
20.
ScarpazzaGMarchiEScaglioneFMontoliCFraschiniFCalzavaraM PCoduriM (1984) Reproterolo e salbutamolo per via orale nel trattamento delle broncopneumopatie croniche ostruttive. Medicina Toracica Suppl. 6, 138.
21.
ShapiroGMcPhillisJ JSmithKFurukawaTPiersonWBiermanC W (1981) Effectiveness of terbutaline and theophylline alone and in combination in exercise-induced bronchospasm. Pediatrics67, 508.
22.
TaboriDČonkićBTodićVMijatovicMMirkovićSZečevićDCampragD (1977) L'azione broncodilatante del reproterolo in pazienti con asma bronchiale o broncopneumopatia cronica ostruttiva. Arzneimittel Forschung (Drug Research)27, (la), 55.
23.
VeriniMChiarelliFDi TullioAMorgeseGPallottaR (1983) Prevenzione farmacologica della broncostruzione indotta dall'esercizio fisico: revisione della letteratura e sperimentazione del disodiocromoglicato, del fenoterolo e del bromuro di ipratropio su una popolazione pediatrica. Pediatria Medica Chirurgica5, 501.
